If the direct antiglobulin test (DAT) is positive, which step is required to identify the underlying antibody?

Master the CAMLPR Transfusion Test with interactive questions and detailed explanations. Boost your knowledge and ensure you're exam-ready with comprehensive study resources!

Multiple Choice

If the direct antiglobulin test (DAT) is positive, which step is required to identify the underlying antibody?

When the direct antiglobulin test is positive, antibodies are bound to the patient's red cells in vivo. To pinpoint which antibody is present, the standard approach is to perform an elution, which removes those bound antibodies from the red cells and yields an eluate containing the antibody. This eluate is then tested against a panel of reagent red cells with known antigen profiles to determine the antibody’s specificity (for example, anti-K, anti-Fya, anti-E, etc.). This method directly reveals which antigen the antibody targets and helps distinguish alloantibodies from autoantibodies or clinically insignificant antibodies. Other options don’t provide the same specificity. ABO typing alone won’t identify the antibody involved. A crossmatch assesses compatibility for a particular donor unit but doesn’t reveal the antibody’s identity. Transfusing red cells before identifying the antibody can complicate the serologic picture and pose a risk of hemolytic reactions, and re-testing after transfusion wouldn’t reliably disclose the underlying antibody specificity.

When the direct antiglobulin test is positive, antibodies are bound to the patient's red cells in vivo. To pinpoint which antibody is present, the standard approach is to perform an elution, which removes those bound antibodies from the red cells and yields an eluate containing the antibody. This eluate is then tested against a panel of reagent red cells with known antigen profiles to determine the antibody’s specificity (for example, anti-K, anti-Fya, anti-E, etc.). This method directly reveals which antigen the antibody targets and helps distinguish alloantibodies from autoantibodies or clinically insignificant antibodies.

Other options don’t provide the same specificity. ABO typing alone won’t identify the antibody involved. A crossmatch assesses compatibility for a particular donor unit but doesn’t reveal the antibody’s identity. Transfusing red cells before identifying the antibody can complicate the serologic picture and pose a risk of hemolytic reactions, and re-testing after transfusion wouldn’t reliably disclose the underlying antibody specificity.

More practice questions